DSVTLA: Deep Swin Vision Transformer-Based Transfer Learning Architecture for Multi-Type Cancer Histopathological Cancer Image Classification

1. Problem Statement

Cancer diagnosis via histopathological image analysis is critical but faces significant challenges:

• Resource Constraints: Manual microscopic inspection is time-consuming, labor-intensive, and prone to inter-observer variability, especially in low-resource settings with a scarcity of trained pathologists.
• Biological Heterogeneity: Cancer diagnosis is complicated by variations in tissue morphology, cellular structure, and genetic mutations, making visual assessment difficult even for experts.
• Limitations of Existing AI Models:
  • CNNs (e.g., ResNet, DenseNet): While effective at capturing local texture patterns, they often struggle to model long-range contextual dependencies crucial for understanding complex tissue structures.
  • Transformers (e.g., ViT, Swin): While excellent at global context, they often require massive datasets and may miss fine-grained local morphological details when used in isolation.
  • Scope Gap: Most existing studies focus on single-cancer classification, lacking unified frameworks capable of distinguishing between multiple cancer types simultaneously under consistent experimental conditions.

2. Methodology

The authors propose DSVTLA, a hybrid deep learning architecture that integrates ResNet50 (Convolutional Neural Network) with the Swin Transformer to leverage the strengths of both paradigms.

A. Dataset and Preprocessing

The study utilizes a comprehensive multi-cancer dataset comprising five distinct cancer types (Breast, Oral, Lung, Colon, Kidney, and Acute Lymphocytic Leukemia) sourced from public repositories.

• Total Images: Approximately 63,000+ images across various modalities (H&E stained slides, CT scans, blood smears).
• Preprocessing: Images are resized to 224×224 pixels, normalized using ImageNet statistics, and augmented (flipping, rotation, color jittering) to prevent overfitting.
• Segmentation: For Leukemia, both original and HSV-threshold segmented images were analyzed to test robustness.

B. Proposed Hybrid Architecture

The core innovation is the Swin-Base + ResNet50 Hybrid Model:

1. Feature Extraction (Local): A ResNet50 backbone extracts fine-grained local features (cellular textures, tissue boundaries) using residual learning.
2. Contextual Modeling (Global): The extracted features are partitioned into non-overlapping windows and fed into a Swin Transformer.
3. Mechanism: The Swin Transformer applies Shifted Window-based Multi-Head Self-Attention (SW-MSA). This allows the model to capture long-range dependencies and global contextual relationships between different tissue regions while maintaining computational efficiency.
4. Classification: Hierarchical features are aggregated via Global Average Pooling (GAP) and passed through a fully connected layer with Softmax for multi-class prediction.

C. Comparative Baselines

The proposed model was benchmarked against a unified pipeline of state-of-the-art models, including:

• CNNs: DenseNet121, DenseNet201, InceptionV3, ResNet50, EfficientNetB3.
• Transformers: Vision Transformer (ViT-Base, ViT-Large), Swin-Tiny, Swin-Base.

D. Explainability (XAI)

To ensure clinical trust, the study employed LIME, SHAP, and Occlusion Sensitivity to visualize which image regions influenced the model's decisions, verifying that the model focuses on clinically relevant morphological features rather than artifacts.

3. Key Contributions

1. Hybrid Architecture: Development of a novel framework combining ResNet50's local feature extraction with Swin Transformer's global attention mechanisms, addressing the limitations of using either architecture alone.
2. Multi-Cancer Unified Framework: A comprehensive evaluation across six diverse cancer categories (Breast, Oral, Lung, Colon, Kidney, ALL) using a single, consistent experimental pipeline, unlike previous single-disease studies.
3. Robustness Validation: Extensive testing on both original and segmented images (specifically for Leukemia) to prove generalization across heterogeneous clinical imaging conditions.
4. Interpretability: Integration of XAI tools to demonstrate that the model's decision-making aligns with pathological standards, enhancing transparency for clinical deployment.

4. Experimental Results

The experiments were conducted on an NVIDIA Tesla P100 GPU using PyTorch. The results demonstrate superior performance by the proposed hybrid model:

• Overall Accuracy: The Swin-Base + ResNet50 hybrid achieved the highest or near-highest accuracy across all categories.
  • Lung & Colon Cancer: 100% Test Accuracy.
  • Acute Lymphocytic Leukemia (Segmented): 100% Test Accuracy.
  • Kidney Cancer: 100% Test Accuracy.
  • Breast Cancer: 99.23% Test Accuracy.
  • Oral Cancer: 98.33% Test Accuracy.
• Stability: The model showed consistent performance across three independent runs, with average test accuracies exceeding 99% for most categories.
• Metrics: The model achieved near-perfect Precision, Recall, and F1-Scores (often 1.00), indicating minimal false positives and negatives.
• Comparison: While some baseline models (e.g., DenseNet201, Swin-Base alone) performed marginally better on isolated datasets (differences <1%), the hybrid model provided the most consistent high performance across all cancer types simultaneously.

5. Significance and Conclusion

• Clinical Impact: The study establishes a robust, scalable, and highly accurate tool for automated histopathological diagnosis, potentially reducing the workload on pathologists and minimizing diagnostic errors in resource-constrained environments.
• Scientific Contribution: It validates that a hybrid approach effectively bridges the gap between local texture analysis (CNN) and global context modeling (Transformer), setting a new benchmark for multi-cancer classification.
• Future Directions: The high interpretability of the model suggests it is ready for integration into Computer-Aided Diagnosis (CAD) systems, facilitating human-AI collaboration in clinical workflows.

In summary, DSVTLA represents a significant advancement in medical AI, offering a unified, interpretable, and highly accurate solution for the complex task of multi-type cancer classification.